FCS Leaders Serve on 2022 Faculty for Value-Based Cancer Care Summit
Fort Myers, Fla., October 19, 2022 – Senior leaders of Florida Cancer Specialists & Research Institute (FCS) will serve on the faculty for the Association for Value-Based Cancer Care 2022 Summit & Educational Program being held in New York, NY on Oct. 19-21. The three-day, invitation-only forum will bring together medical experts and influential leaders representing every aspect of cancer care delivery to focus on clinical, cost and access issues designed to maximize value in cancer care.
Joining the diverse roster of panelists are:
- FCS Chief Executive Officer Nathan H. Walcker – Community Cancer Care and Its Future Ahead
- FCS Chief Medical Officer for Therapeutics and Analytics Lucio N. Gordan, MD – Cancer Research and the Road Ahead
- FCS Senior Vice President of Pharmacy Services Ray Bailey, BPharm, RPH – Medically Integrated Pharmacy and Future Models of Integration
“We place great value on this opportunity to gather with other leading innovators to learn, brainstorm and network,” said Lucio Gordan, MD, FCS Chief Medical Officer for Therapeutics and Analytics. “Together we will contribute to lasting improvements that will change lives and advance cancer care.”
Florida Cancer Specialists & Research Institute has been a recognized leader in value-based oncology care efforts through is achievements in the Oncology Care Model (OCM) and through innovative partnerships with commercial payors. The state-wide community oncology practice continues to evolve its value-based strategies, requiring alignment both internally with providers and a dedicated care management team, as well as externally with payors.
FCS CEO Nathan H. Walcker said, “The AVBCC Summit serves as a catalyst for shaping the future of cancer care. My FCS colleagues and I are pleased to share our insights and best practice strategies for enhancing access, clinical quality and the overall value of the cancer care ecosystem.”
Over the past several years, FCS has created an infrastructure to enhance the quality and reducing the cost of patient care including data management, innovative technology, utilization of biosimilar drugs and processes to improve patient access to care. To learn more about value-based care efforts at FCS, visit: https://flcancer.com/value-based-care/.